References
- SiegelRLMillerKDJemalACancer statistics, 2016CA Cancer J Clin20166673026742998
- BriggerIDubernetCCouvreurPNanoparticles in cancer therapy and diagnosisAdv Drug Deliv Rev20025463165112204596
- WuQYangZNieYShiYFanDMulti-drug resistance in cancer chemotherapeutics: mechanisms and lab approachesCancer Lett201434715916624657660
- LeharJKruegerASAveryWSynergistic drug combinations tend to improve therapeutically relevant selectivityNat Biotechnol20092765966619581876
- LiuZJiaoYWangYZhouCZhangZPolysaccharides-based nanoparticles as drug delivery systemsAdv Drug Deliv Rev2008601650166218848591
- TianGZhengXZhangXTpgs-stabilized Naybf4:Er upconversion nanoparticles for dual-modal fluorescent/Ct imaging and anticancer drug delivery to overcome multi-drug resistanceBiomaterials20154010711625433607
- SongLPanZZhangHDually folate/Cd44 receptor-targeted self-assembled hyaluronic acid nanoparticles for dual-drug delivery and combination cancer therapyJ Mater Chem B2017568356846
- ThomasTPHuangBChoiSKPolyvalent dendrimer-methotrexate as a folate receptor-targeted cancer therapeuticMol Pharm201292669267622827500
- RobertsGCFeeneyJBirdsallBCharltonPYoungDMethotrexate binding to dihydrofolate reductaseNature19802863097402318
- ZebAQureshiOSKimHSChaJHKimHSKimJKImproved skin permeation of methotrexate via nanosized ultradeformable liposomesInt J Nanomedicine2016113813382427540293
- BoechatALDe OliveiraCPTarragoAMMethotrexate-loaded lipid-core nanocapsules are highly effective in the control of inflammation in synovial cells and a chronic arthritis modelInt J Nanomedicine2015106603661426543364
- MountCFeatherstoneJRheumatoid arthritis marketNat Rev Drug Discov20054111215690597
- CronsteinBNLow-dose methotrexate: a mainstay in the treatment of rheumatoid arthritisPharmacol Rev20055716317215914465
- ShaoZShaoJTanBTargeted lung cancer therapy: preparation and optimization of transferrin-decorated nanostructured lipid carriers as novel nanomedicine for co-delivery of anticancer drugs and DNAInt J Nanomedicine2015101223123325709444
- AggarwalBBKumarABhartiACAnticancer potential of curcumin: preclinical and clinical studiesAnticancer Res20032336339812680238
- BanerjeeSChakravartyARMetal complexes of curcumin for cellular imaging, targeting, and photoinduced anticancer activityAcc Chem Res2015482075208326158541
- XieJLiYSongLPanZYeSHouZDesign of a novel curcumin-soybean phosphatidylcholine complex-based targeted drug delivery systemsDrug Deliv20172470771928436718
- ZhaoXChenQLiuWCodelivery of doxorubicin and curcumin with lipid nanoparticles results in improved efficacy of chemotherapy in liver cancerInt J Nanomedicine20151025727025565818
- KetronACGordonONSchneiderCOsheroffNOxidative metabolites of curcumin poison human type II topoisomerasesBiochemistry20135222122723253398
- ZhangYYangCWangWCo-delivery of doxorubicin and curcumin by ph-sensitive prodrug nanoparticle for combination therapy of cancerSci Rep201662122526876480
- HeSQiYKuangGSingle-stimulus dual-drug sensitive nano-platform for enhanced photoactivated therapyBiomacromolecules2016172120212727169722
- PeerDKarpJMHongSFarokhzadOCMargalitRLangerRNanocarriers as an emerging platform for cancer therapyNat Nanotechnol2007275176018654426
- WangKHuangQQiuFSuiMNon-viral delivery systems for the application in P53 cancer gene therapyCurr Med Chem2015224118413626423086
- WenRBanikBPathakRKKumarAKolishettiNDharSNanotechnology inspired tools for mitochondrial dysfunction related diseasesAdv Drug Deliv Rev201699526926776231
- ZhangBWangKSiJSuiMShenYCharge-reversal polymers for biodeliveryGuZBioinspired and Biomimetic Polymer Systems for Drug and Gene DeliveryDarmstadtWiley-VCH Verlag GmbH Co., KGaA2014223242
- ShiJKantoffPWWoosterRFarokhzadOCCancer nanomedicine: progress, challenges and opportunitiesNat Rev Cancer201717203727834398
- PangXJiangYXiaoQLeungAWHuaHXuCpH-responsive polymer-drug conjugates: design and progressJ Control Release201622211612926704934
- CaiYSunZFangXSynthesis, characterization and anti-cancer activity of pluronic F68-curcumin conjugate micellesDrug Deliv2016232587259526066393
- ZhaoYRenWZhongTTumor-specific ph-responsive peptide-modified ph-sensitive liposomes containing doxorubicin for enhancing glioma targeting and anti-tumor activityJ Control Release2016222566626682502
- LiangWChowMYLauPNInhalable dry powder formulations of sirna and ph-responsive peptides with antiviral activity against H1n1 influenza virusMol Pharm20151291092125599953
- MaedaHWuJSawaTMatsumuraYHoriKTumor vascular permeability and the Epr effect in macromolecular therapeutics: a reviewJ Control Release20006527128410699287
- BertrandNWuJXuXKamalyNFarokhzadOCCancer nanotechnology: the impact of passive and active targeting in the era of modern cancer biologyAdv Drug Delivey Rev201466225
- YanJWangYZhangXLiuSTianCWangHTargeted nanomedicine for prostate cancer therapy: docetaxel and curcumin co-encapsulated lipid-polymer hybrid nanoparticles for the enhanced anti-tumor activity in vitro and in vivoDrug Deliv2016231757176226203689
- DuncanRPolymer conjugates as anticancer nanomedicinesNat Rev Cancer2006668870116900224
- WagnerVDullaartABockAKZweckAThe emerging nanomedicine landscapeNat Biotechnol2006241211121717033654
- LukyanovANTorchilinVPMicelles from lipid derivatives of water-soluble polymers as delivery systems for poorly soluble drugsAdv Drug Deliv Rev2004561273128915109769
- LiYLinJWuHOrthogonally functionalized nanoscale micelles for active targeted codelivery of methotrexate and mitomycin C with synergistic anticancer effectMol Pharm20151276978225625539
- ChenYZhangWHuangYThe therapeutic effect of methotrexate-conjugated pluronic-based polymeric micelles on the folate receptor-rich tumors treatmentInt J Nanomedicine2015104043405726150715
- LiYSongLLinJProgrammed nanococktail based on pH-responsive function switch for self-synergistic tumor-targeting therapyACS Appl Mater Interfaces20179391273914229039650
- TorchilinVTumor delivery of macromolecular drugs based on the epr effectAdv Drug Delivey Rev201163131135
- LiYLinJHuangYSelf-targeted, shape-assisted, and controlled-release self-delivery nanodrug for synergistic targeting/anticancer effect of cytoplasm and nucleus of cancer cellsACS Appl Mater Interfaces20157255532555926529185
- HuMHuangPWangYSuYZhouLZhuXYanDSynergistic combination chemotherapy of camptothecin and floxuridine through self-assembly of amphiphilic drug-drug conjugateBioconjug Chem2015262497250626497258
- LiYLinJYangXSelf-assembled nanoparticles based on amphiphilic anticancer drug-phospholipid complex for targeted drug delivery and intracellular dual-controlled releaseACS Appl MaterInterfaces201571757317581
- BeuraLKHamiltonSEBiKNormalizing the environment recapitulates adult human immune traits in laboratory miceNature201653251227096360
- BreschiAGingerasTRGuigoRComparative transcriptomics in human and mouseNat Rev Genet20171842544028479595
- ZalipskySBrandeisENewmanMSWoodleMCLong circulating, cationic liposomes containing amino-peg-phosphatidylethanolamineFEBS Lett199435371747926026
- ZhengJNXieHGYuWTChitosan-G-Mpeg-modified alginate/chitosan hydrogel microcapsules: a quantitative study of the effect of polymer architecture on the resistance to protein adsorptionLangmuir201026171561716420949965
- LiYLinJWuHNovel methotrexate prodrug-targeted drug delivery system based on peg-lipid-PLA hybrid nanoparticles for enhanced anticancer efficacy and reduced toxicity of mitomycin CJ Mater Chem B2014265346548
- GuoYZhangYMaJLight/magnetic hyperthermia triggered drug released from multi-functional thermo-sensitive magnetoliposomes for precise cancer synergetic theranosticsJ Control Release Epub2017422
- LiuGMaJLiYCore-interlayer-shell Fe3o4@Msio2@lipid-PEG-methotrexate nanoparticle for multimodal imaging and multistage targeted chemo-photodynamic therapyInt J Pharm2017521193228163230